LivaNova PLC (NASDAQ:LIVN) fell 1.6% during trading on Monday . The stock traded as low as $49.33 and last traded at $49.37, with a volume of 237,016 shares changing hands. The stock had previously closed at $50.19.

Separately, Piper Jaffray Cos. restated an “overweight” rating and set a $59.00 price objective (down previously from $61.00) on shares of LivaNova PLC in a report on Thursday, July 7th. Five equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. LivaNova PLC has an average rating of “Hold” and an average target price of $66.25.

The stock has a 50 day moving average of $49.43 and a 200 day moving average of $52.98. The company’s market capitalization is $2.42 billion.

In other LivaNova PLC news, Director Alfred J. Novak sold 4,000 shares of the business’s stock in a transaction dated Friday, May 6th. The stock was sold at an average price of $51.12, for a total transaction of $204,480.00. Following the completion of the sale, the director now owns 13,020 shares of the company’s stock, valued at $665,582.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Hugh M. Morrison sold 3,600 shares of the business’s stock in a transaction dated Thursday, May 19th. The shares were sold at an average price of $48.00, for a total value of $172,800.00. Following the sale, the director now directly owns 5,215 shares of the company’s stock, valued at approximately $250,320. The disclosure for this sale can be found here.

Other hedge funds recently added to or reduced their stakes in the company. Schroder Investment Management Group bought a new stake in LivaNova PLC during the fourth quarter valued at about $22,818,000. Principal Financial Group Inc. bought a new stake in LivaNova PLC during the fourth quarter valued at about $7,987,000. Wells Fargo & Company MN bought a new stake in LivaNova PLC during the fourth quarter valued at about $30,246,000. Fernwood Investment Management LLC bought a new stake in LivaNova PLC during the fourth quarter valued at about $1,032,000. Finally, Morgan Stanley bought a new stake in LivaNova PLC during the fourth quarter valued at about $1,985,000.

LivaNova PLC is a United Kingdom-based medical technology company. The Company focuses on providing treatment for cardiovascular diseases and neuromodulation. The Company operates under three business units: Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation. The Company provides solutions for patients, healthcare professionals and healthcare systems.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.